Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.
Overview
Overview of Xarelto® and its pharmaceutical context in Canada.
Xarelto® contains the active ingredient rivaroxaban, a direct factor Xa inhibitor used as an oral anticoagulant. In Canada, it is marketed exclusively under the brand name Xarelto® by Bayer Inc. Competing brands with similar anticoagulant effects include Eliquis® (apixaban), Pradaxa® (dabigatran), and Lixiana® (edoxaban). Xarelto® is approved by Health Canada with a Drug Identification Number (DIN) and is listed under BC PharmaCare formularies.
How Xarelto® Works
How Xarelto® works at a biological level to affect blood clotting.
Rivaroxaban selectively blocks factor Xa, an essential enzyme in the blood clotting process. By inhibiting factor Xa, Xarelto® reduces the formation of thrombin, a protein needed to form blood clots. This action helps regulate clotting without directly affecting platelets.
Dosage Instructions of Xarelto®
Available Xarelto® formats approved in Canada.
Xarelto® is available as film-coated tablets in strengths of 10 mg, 15 mg, and 20 mg. These tablets have a characteristic orange color and are intended for oral administration.
General guidelines for taking Xarelto® safely.
Xarelto® tablets should be taken orally with water, with or without food depending on the dose. Consistency in the timing of doses is important. Dosage adjustments may be required based on kidney function and other factors. Always follow the healthcare provider’s prescription instructions.
Storage Instructions
Proper storage conditions for Xarelto® tablets. Store Xarelto® tablets at room temperature (15°C to 30°C), away from moisture and heat. Keep out of reach of children and do not use after the expiration date.
Side Effects of Xarelto®
Common and serious side effects linked to Xarelto®.
Common side effects include bleeding-related events such as bruising or nosebleeds. Serious side effects may involve severe bleeding, allergic reactions, or liver enzyme changes. Patients should report any unusual bleeding or symptoms promptly to a healthcare professional.
Important Safety Information About Xarelto®
Key Health Canada safety warnings and precautions.
Health Canada warns that Xarelto® increases bleeding risk and should be used cautiously in patients with kidney impairment or bleeding disorders. It is important to inform your doctor of all medical conditions and medications before starting Xarelto®.
Drug Interactions
Substances and medications to avoid with Xarelto®.
Xarelto® may interact with other blood thinners, certain antifungal and antibiotic drugs, and medications affecting liver enzymes. Avoid taking over-the-counter NSAIDs or supplements without consulting a healthcare provider.
Brands & DIN Number of Xarelto®
Brand Names
- Eliquis®
- Pradaxa®
- Lixiana®
Key Takeaways
- 1• Xarelto® contains rivaroxaban, a direct factor Xa inhibitor.
- 2• Available in 10 mg, 15 mg, and 20 mg oral tablets in Canada.
- 3• Used to reduce blood clotting by blocking factor Xa enzyme.
- 4• Requires a prescription and professional medical guidance.
- 5• Common side effects include bleeding; serious risks must be monitored.
- 6• Store tablets at room temperature, away from moisture and heat.
- 7• Avoid interacting medications without doctor consultation.